Financial News Feed

Stronger Sell Today AIMT ranks #2394 as SELL CANDIDATE. Weaker Sell
Today AIMT ranks #2394 as SELL CANDIDATE.

AIMT stock Aimmune Therapeutics

AIMT stock
Aimmune Therapeutics

Traders may be watching short-term indicators on shares of Aimmune Therap (AIMT). Currently, the 7-day average directional indicator is Sell. This signal may be used to determine the market trend. The...

Read more

Aimmune Therapeutics, Inc. (NASDAQ:AIMT) closed at $22.17 after seeing 659357 shares trade hands during the most recent session. This represents a change of -0.72% from the opening. The shares have mo...

Read more

Aimmune Therapeutics (AIMT) Rating Reaffirmed Recently, In analysts note issued to clients and investors on 25 March, Aimmune Therapeutics (AIMT) shares have had their Buy Rating restate by equity ana...

Read more

The stock of Aimmune Therapeutics, Inc. (NASDAQ:AIMT) is a huge mover today! The stock increased 4.19% or $0.9 during the last trading session, reaching $22.38. About 382,703 shares traded. Aimmune Th...

Read more

Both AgeX Therapeutics Inc. (NYSEAMERICAN:AGE) and Aimmune Therapeutics Inc. (NASDAQ:AIMT) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with regar...

Read more

The stock rating of Aimmune Therapeutics (AIMT) was reconfirmed by research professionals at Stifel Nicolaus. This was revealed in a research report on 25 March. Carrizo Oil & Gas Inc (NASDAQ:CRZO) ha...

Read more

In a report released today, Derek Archila from Stifel Nicolaus reiterated a Hold rating on Aimmune Therapeutics (AIMT). The company’s shares opened today ... The post Stifel Nicolaus Remains a Hold ...

Read more

We are comparing Global Cord Blood Corporation (NYSE:CO) and Aimmune Therapeutics Inc. (NASDAQ:AIMT) on their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings...

Read more

Narrowing in on shares of Aimmune Therap (AIMT), we can see that the current 20-Day Bollinger Bands signal is currently reading Hold. This short-term indicator can be used to help identify oversold an...

Read more

XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) and Aimmune Therapeutics Inc. (NASDAQ:AIMT), are influenced by compare since they are both players in the...

Read more

Aimmune Therap (AIMT) shares are being watched closely by traders as the Awesome Oscillator signal is revealing a downward trend building over the past five bars, signaling that market momentum is bui...

Read more

This is a contrast between Aimmune Therapeutics Inc. (NASDAQ:AIMT) and Stellar Biotechnologies Inc. (NASDAQ:SBOT) based on their institutional ownership,...

Read more

Jaguar Health Inc. (NASDAQ:JAGX) and Aimmune Therapeutics Inc. (NASDAQ:AIMT), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influence the ...

Read more

Brisbane, Calif.-based Aimmune Therapeutics announced that its Phase III European clinical trial of AR101 for treatment of peanut allergy met its primary efficacy endpoint....

Read more

Brisbane, Calif.-based Aimmune Therapeutics announced that its Phase III European clinical trial of AR101 for treatment of peanut allergy met its primary efficacy endpoint....

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank